Abbvie, Inc. (ABBV) Tops Q3 EPS by 4c; Boosts FY13 EPS Outlook
Abbvie, Inc. (NYSE: ABBV) reported Q3 EPS of $0.82, $0.04 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)